An Alarming Number of Clinical Trials Are Greenlit Based on Shockingly Poor Data
Most aren't even published.
MIKE MCRAE
6 APR 2018
To make a call on whether the first phase of a clinical trial is to go ahead, a board of experts weighs up the risk and benefits based on sound research. At least, that's the idea.
Now a recently published study on the evidence that informs these decisions, says it might not be as rigorous as we'd like it to be.
https://www.sciencealert.com/limited-data-included-pre-clinical-investigator-brochures-german-review-boards
